Publikasi

Could ticketing experts solve ORE booking bottlenecks?

We hear from two online queueing specialists on what the General Dental Council ...

Dr Reddy’s registers PD-1 inhibitor for recurrent or me...

Dr Rashem Mothilal explains how the registration aims to expand access to immun...

How Permanente Medicine is helping unlock the promise o...

Maisha Draves, MD, MPH, explains the potential of biosimilars in health care to ...

Combined Phage Therapy and FMT Reduces Recurrent UTIs a...

The first use of combined phage therapy and fecal microbiota transplantation for...

The Physicians Foundation Opens Nominations for the Dr....

National award recognizes physicians confronting the drivers of health that make...

Evolutionarily Diverse Organisms Switch Genes on Simply...

A new study has found that the signals cells use to switch genes on have remaine...

New Research Greenlights Popular Obesity Medications fo...

Popular diabetes and weight-loss medications known as GLP-1 receptor agonists do...

Following court decision, Arkansas will not enforce Act...

On Tuesday July 28, the Arkansas State Board of Pharmacy suspended enforcement o...

BIO 2026: How biotechs break the $100M barrier in fundi...

The tap is opening up for venture capital in the biotech industry. Venture inves...

Receptor.AI and Sethera Plan to Create Closed-Loop Disc...

The collaboration is specifically focused on applying Receptor.AI's computationa...

Derm Deep Dive: The Best Products and Treatments for Ha...

How to Get the Most from a Hair Regrowth Plan  When you’re dealing with hair los...

Dentists’ taxable income rises across UK, with Scotland...

Self-employed dentists with some NHS or health service work saw taxable income r...

Ratio Therapeutics secures $70m Series C funding for ca...

The company said existing investors Duquesne Family Office and Bristol Myers Squ...

IMPACT Therapeutics grants Pharmanovia exclusive $488m ...

The agreement covers the use of senaparib as a maintenance monotherapy for adult...

Eisai launches LEQEMBI in India for early Alzheimer’s d...

Launch follows CDSCO marketing authorisation for disease-modifying therapy ind...

Encube Ethicals files DRHP with SEBI for Rs 3,000 crore...

IPO comprises an offer for sale by promoters and investor selling shareholder t...